| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | 3 | — | — | — | — |
| Sell | — | — | — | — | — | — | — | — | — | — | 1 | — |
| total | individual payouts | |
|---|---|---|
| 2028 | ‡‡‡ |
|
| 2027 | ‡‡‡‡‡ |
|
| 2026 | 2.03 |
—
—
—
|
| 2025 | 1.80 |
—
—
—
—
|
| 2024 | 1.60 |
—
—
—
—
|
| 2023 | 1.40 |
—
—
—
—
|
| 2022 | 1.20 |
—
—
—
—
|
| 2021 | 0.80 |
—
—
—
—
|
| 2020 | 0.60 |
—
—
—
—
|
| 2019 | 0.40 |
—
—
—
—
|
| 2018 | 0.24 |
—
—
—
—
|
| 2017 | 0.12 |
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 514.12 | 492.67 | 602.36 | 471.31 |
| Receivables | 139.85 | 113.65 | 119.95 | 126.20 |
| Inventory | 175.80 | 182.94 | 240.91 | 249.65 |
| Other | 87.37 | 110.58 | 123.84 | 94.60 |
| 917.13 | 899.83 | 1,087.06 | 941.76 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 10.93 | 36.59 | 23.34 | 18.60 |
| ST’ Debt | — | — | — | — |
| Other | 8.10 | 9.72 | 11.09 | 11.58 |
| 118.82 | 125.41 | 108.01 | 110.82 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 142.21 | 152.16 | — | — |
—
|
| ’25 | 166.28 | 171.79 | 139.61 | 172.93 |
650.61
|
| ’24 | 165.26 | 158.51 | 161.63 | 162.29 |
647.68
|
| ’23 | 130.47 | 146.57 | 141.08 | 158.32 |
576.43
|
| ’22 | 150.47 | 136.56 | 160.56 | 169.03 |
616.62
|
| ’21 | 134.00 | 129.66 | 143.62 | 146.25 |
553.53
|
| ’20 | 112.28 | 57.97 | 117.08 | 141.54 |
428.87
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 108.88 | 24.98 | — | — |
—
|
| ’25 | 30.56 | 51.94 | 97.18 | 31.15 |
210.83
|
| ’24 | 72.16 | 67.01 | 79.86 | 34.71 |
253.74
|
| ’23 | 47.62 | 9.78 | 60.31 | 37.07 |
154.78
|
| ’22 | 52.61 | 33.52 | 38.04 | 2.64 |
126.82
|
| ’21 | 29.50 | 29.62 | 75.21 | 56.78 |
191.11
|
| ’20 | 5.75 | 26.28 | 43.80 | 72.97 |
148.79
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 60.27 | 20.35 | — | — |
—
|
| ’25 | 17.50 | 37.46 | 84.34 | 5.06 |
144.36
|
| ’24 | 64.95 | 57.89 | 66.23 | 22.04 |
211.10
|
| ’23 | 38.47 | (74.41) | 34.88 | 29.49 |
28.42
|
| ’22 | 41.85 | 22.94 | 23.51 | (8.68) |
79.61
|
| ’21 | 19.26 | 18.79 | 66.38 | 43.11 |
147.55
|
| ’20 | 0.96 | 19.24 | 36.39 | 64.15 |
120.74
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 0.76 | 1.06 | — | — |
—
|
| ’25 | 1.35 | 1.41 | 0.92 | 1.39 |
5.08
|
| ’24 | 1.19 | 1.10 | 1.40 | 0.96 |
4.65
|
| ’23 | 0.83 | 1.04 | 1.08 | 1.29 |
4.24
|
| ’22 | 1.05 | 0.87 | 1.12 | 1.36 |
4.40
|
| ’21 | 1.08 | 0.85 | 0.97 | 0.96 |
3.87
|
| ’20 | 0.80 | 0.02 | 0.85 | 1.13 |
2.80
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 89.41 | 105.73 | 145.26 | 103.70 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 178.75 | 194.84 | 237.00 | 164.29 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 445 | 456 | 468 | 469 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.39 | 1.26 | 1.38 | 1.39 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 616.62 | 576.43 | 647.68 | 650.61 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 79.26% | 76.51% | 77.08% | 76.31% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 268.23 | 245.17 | 272.13 | 294.80 | ‡‡‡‡‡ | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 43.50% | 42.53% | 42.02% | 45.31% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 210.06 | 203.01 | 222.08 | 242.08 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 35.81 | 43.40 | 44.14 | 46.59 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 13.01 | 12.12 | 13.62 | 13.68 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | 4.41 | 4.25 | 4.66 | 5.09 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.68 | 3.25 | 5.34 | 4.43 | ‡‡‡‡ | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.00) | (2.66) | (0.90) | (1.40) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.68 | 0.60 | 4.44 | 3.04 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 26.91 | 30.43 | 34.00 | 37.04 | ‡‡‡‡ | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 47.39 | 47.56 | 47.55 | 47.55 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 24.14 | 43.90 | 31.37 | 22.94 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.20 | 15.39 | 10.73 | 8.53 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.96 | 6.13 | 4.30 | 3.15 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7.32 | 14.55 | 10.01 | 7.65 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 56.67 | 295.04 | 44.87 | 63.92 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 126.82 | 154.78 | 253.74 | 210.83 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (47.21) | (126.35) | (42.64) | (66.47) | ‡‡‡‡‡ | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 79.61 | 28.42 | 211.10 | 144.36 | ‡‡‡‡‡ | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 763.75 | 798.31 | 774.42 | 979.05 | — | — | — |
Working Cap'
|
| — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 33.00 | — | — | — | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (544.77) | (514.12) | (492.67) | (602.36) | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,275.37 | 1,447.23 | 1,616.53 | 1,761.02 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 13.92% | 12.62% | 12.66% | 12.75% | ‡‡‡‡ | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 22.85% | 14.55% | 13.28% | 13.41% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 17.58% | 14.84% | 14.46% | 14.33% | ‡‡‡‡‡ | — | — |
ROE
|
Universal Display Corporation (OLED), a leader in phosphorescent OLED materials powering premium displays in smartphones, TVs, and wearables, trades at a compelling 24% discount to average analyst price targets, signaling recovery potential amid cyclical sector dynamics. Despite moderating gross margins and scant insider buying, the company’s fortress balance sheet, surging free cash flow ($4.44 per share in 2024), and resilient IP licensing to giants like Samsung and LG underpin stability, even as U.S.-China tensions add volatility.
Historical revenue has compounded at 12% CAGR over the past decade to $648 million in 2024, with EBT margins above 40% and ROIC superior to peers, fueled by smartphone and TV OLED adoption. Stock performance has mirrored sector booms and busts—peaking at $263 in 2021 before halving—yet current multiples (31x trailing P/E, 10.7x P/S) reflect de-rating, positioning OLED for upside if fundamentals hold.
Analysts project 12-13% revenue CAGR through 2027 ($807 million), EPS to $6.40 (+37%), and net income to $307 million, driven by foldables, automotive, and AR/VR tailwinds like Apple Vision Pro. With mean targets implying 32% gains and potential P/E re-rating to 20-25x, OLED offers high-conviction exposure to display onshoring and AI upgrades—though margin pressures and China risks warrant caution.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.